The writing is on the wall for the Toronto Maple Leafs. Firmly shifting their eyes toward selling, the Maple Leafs announced they had scratched Oliver Ekman-Larsson, Scott Laughton, and Bobby McMann ...

Teledyne Technologies Incorporated (NYSE:TDY), a global leader in advanced imaging and sensor solutions, is pleased to announce the start of production on multiple awards to deliver state-of-the-art ...

MOBILE, AL — There are no shortage of needs for the 2026 Miami Dolphins roster. Miami has acknowledged, through new general manager Jon-Eric Sullivan and head coach Jeff Hafley, that the goal is to ...

Chinese artificial intelligence startup MiniMax today announced the release of M2.1, a significantly enhanced performance for real-world complex tasks and agentic capabilities across more programming ...

Texas Rangers president of baseball, Chris Young (left) and general manager Ross Fenstermaker listen during a post season press conference, on Friday, Oct. 3, 2025, at Globe Life Field in Arlington.

CINCINNATI — Brendan Sorsby is already getting serious offers from other football programs, according to the latest report from CBS Sports analyst Rick Neuheisel. He noted on his CBS Sports Radio show ...

Keon Coleman was a healthy scratch on Sunday as the Bills beat the Buccaneers, 44-32. Coleman was late for a team meeting and benched by coach Sean McDermott ahead of the game against Tampa Bay. After ...

Especially after the disappointing Buffalo Bills offensive performance in the upset loss to the Dolphins last week, one would've assumed that Sean McDermott and Company were about to come back in full ...

LOWELL — The Merrimack Repertory Theatre Board of Trustees announced Wednesday that Nancy L. Donahue Executive Artistic Director Courtney Sale will step down from her role in January and assume the ...

Board of Trustees announced today that Courtney Sale, Nancy L. Donahue Executive Artistic Director, will step down from her role in January 2026 and assume the Executive Director position at the 1932 ...

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. The Japanese pharma had been evaluating the alpha-synuclein antibody, called ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...